When it comes to developing heart disease, patients who have non-alcoholic steatohepatitis (NASH) are at greater risk of both cardiovascular illness and death than patients with non-alcoholic fatty liver disease (NAFLD, a UK team reported today at the International Liver Congress in Vienna, Austria. Jake Mann, MD, of the department of pediatrics at the University of Cambridge, Cambridge, UK and colleagues reported on a cohort of almost 1 million UK residents.

“Inflammation changes blood clotting and that could be having an effect,” Mann said, presenting the results at a news conference April 24. Also some of the conditions that lead to liver disease are also risk factors for cardiovascular problems.